6533b7d4fe1ef96bd1261d1d
RESEARCH PRODUCT
Therapy of erectile dysfunction (ED) with sildenafil improves quality of life (QoL) and partnership (QoP)
Matthias J. Müllersubject
medicine.medical_specialtySildenafilbusiness.industrymedia_common.quotation_subjectPersonal distressHuman sexualityOrgasmmedicine.diseasechemistry.chemical_compoundSexual desireSexual dysfunctionErectile dysfunctionchemistryQuality of lifePhysical therapyMedicinemedicine.symptombusinessClinical psychologymedia_commondescription
According to Maslow [1] and others, higher levels of individual and social functioning can only be achieved and maintained, when more basic and particularly physiological levels of functioning are satisfactory and healthy (Fig. 1). Satisfactory partnership and sexuality are core aspects of human wellbeing through the complete course of adulthood. Sexual activity is a major determinant of sexual satisfaction [2]. In men and women, sexual dysfunction as a disorder of sexual desire, arousal, or orgasm, and/or sexual pain results in personal distress and reduced quality of life and interpersonal relationships [3, 4, 5, 6]. Erectile dysfunction (ED) as the inability to attain or maintain penile erection sufficient for satisfactory sexual performance is age-associated, with estimated prevalence rates of 25–40% among men 40 years old and 60–70% among those 70 years old. ED is a common and multifactorial disease due to organic and/or psychological factors [4, 7].
year | journal | country | edition | language |
---|---|---|---|---|
2004-01-01 |